Home › Funds › Duquesne Family Office LLC › RGEN

Duquesne Family Office LLC position in RGEN

REPLIGEN CORP · Health Care

Duquesne Family Office LLC reported holding 77,400 shares of RGEN (REPLIGEN CORP) in its Q3 2026 13F filing — a position valued at US$14.9M, representing 0.40% of its reported portfolio and ranking #44 among its reported holdings. Duquesne Family Office LLC has disclosed RGEN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)77.40K sh
Reported value held$14.88M
Portfolio Weight0.40%
First reportedQ2 2026
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Duquesne Family Office LLC's RGEN position evolved

Duquesne Family Office LLC first disclosed a stake in RGEN in Q2 2026 at 77,400 shares (US$10.6M). The position peaked in Q3 2026 at 77,400 shares, worth US$14.9M. Across 2 filings, Duquesne Family Office LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 77,400 shares valued at US$14.9M.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 77.40K $10.56M New
Q3 2026 77.40K $14.88M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGEN and 13F data

RGEN (REPLIGEN CORP) is a Health Care company. 35 other funds we track also report a position in RGEN — the largest reported positions include UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$536.3M), MAVERICK CAPITAL LTD (US$272.5M), Maverick Capital (US$270.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGEN

All RGEN fund holders →

FAQ

How long has Duquesne Family Office LLC held RGEN?

Duquesne Family Office LLC has disclosed RGEN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Duquesne Family Office LLC's current position in RGEN?

As of Q3 2026, Duquesne Family Office LLC holds 77.40K shares of RGEN (REPLIGEN CORP), valued at $14.88M, representing 0.40% of its reported portfolio and ranking #44.

Has Duquesne Family Office LLC been buying or selling RGEN?

In the latest 13F filing (Q3 2026), Duquesne Family Office LLC held unchanged its position in RGEN. The position peaked in Q3 2026 at 77.40K shares.

Which other funds hold RGEN?

Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, MAVERICK CAPITAL LTD, Maverick Capital, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.